“CPRI Shareholder Alert: Important Announcement from Bronstein, Gewirtz & Grossman, LLC”

Class Action Lawsuit Filed Against Capri Holdings Limited New York City, NY / ACCESS Newswire / January 24, 2025 Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Capri Holdings Limited (“Capri” or “the Company”) (NYSE:CPRI) and certain of its officers. This lawsuit…

Read More

Warning: Unregulated Cannabis Can Be a Real Moldy Mess! Curaleaf’s Report Reveals Health Risks of Online Purchases

Warning: Unregulated Cannabis Can Be a Real Moldy Mess! Curaleaf’s Report Reveals Health Risks of Online Purchases Illegal cannabis sales through unregulated online retailers have increased 50% in the past two years. 73% of the illegal online market is driven by those seeking relief from health conditions. Tests show illegal cannabis in the UK contains…

Read More

Churchill Downs Racetrack to Temporarily Halt Racing Operations for Comprehensive Safety Evaluation

Remainder of Spring Meet will be Relocated to Ellis Park Churchill Downs Racetrack to Suspend Racing Operations to Thoroughly Examine Safety Measures LOUISVILLE, Ky., June 02, 2023 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or the “Company”) (Nasdaq: CHDN) announced today that the Company will suspend racing operations at Churchill Downs Racetrack (“Churchill Downs”) beginning…

Read More

Breaking News: Pasithea Therapeutics Reaches Comprehensive Settlement Agreement with The Camac Group

Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group MIAMI BEACH, Fla., Dec. 12, 2022 (GLOBE NEWSWIRE) Pasithea Therapeutics Corp. (Nasdaq: KTTA) Pasithea Therapeutics Corp., a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (CNS) disorders, today announced that it has reached a comprehensive Settlement and…

Read More

“Attention APLT Investors: Important Announcement from Robbins Geller Rudman & Dowd LLP Regarding Applied Therapeutics Inc. Securities Class Action Lawsuit”

Robbins Geller Rudman & Dowd LLP Announces Deadline for Applied Therapeutics, Inc. Investors Seeking Lead Plaintiff for Class Action Lawsuit SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) Investors who purchased or acquired Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, have until Tuesday, February 18, 2025 to seek appointment…

Read More

“Join the Schall Law Firm in Seeking Justice for Shareholders with Losses”

Investors Beware: Class Action Lawsuit Against Cardlytics, Inc. The Schall Law Firm Reminds Investors of Potential Violations LOS ANGELES, CA / ACCESS Newswire / February 7, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, is currently reminding investors of a class action lawsuit against Cardlytics, Inc. (“Cardlytics” or “the Company”) (NASDAQ:CDLX)…

Read More